@article{4f051b614bf3449cb41b64e867934f39,
title = "Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer",
keywords = "breast cancer, triple negative, chemotherapy, Bevacizumab, survival",
author = "R. Bell and J. Brown and M. Parmar and M. Toi and T. Suter and G.G Steger and X. Pivot and J. Mackey and C. Jackisch and R. Dent and Peter Hall and N. Xu and L. Morales and L. Provencher and R. Hegg and L. Vanlemmens and A. Kirsch and A. Schneeweiss and N. Masuda and F. Overkamp and David Cameron",
year = "2016",
month = dec,
day = "19",
doi = "10.1093/annonc/mdw665",
language = "English",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Elsevier",
}